Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, cbdMD, Inc. reported revenue of $19M, down 1.5% year over year. Operating margin was -11.3% and net margin -10.6%, on a free-cash-flow margin of -8.5% with capital expenditure at 1.0% of revenue. Every figure is computed directly from YCBD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $19M | -11.3% | -10.6% |
| FY2024 | $19M | -17.0% | -19.0% |
| FY2023 | $24M | -93.1% | -95.0% |
| FY2022 | $35M | -221.1% | -198.0% |
| FY2021 | $44M | -44.1% | -52.6% |
How does YCBD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.